FIELD: medicine.
SUBSTANCE: group of inventions relates to an improved method of controlling glycemia in a patient with the second type of diabetes, who is being treated with a suppressor of glucose production by the liver, including a stage of introduction of a superfast-acting insulin preparation to the patient in the mode of glycemia control, where the superfast-acting insulin preparation is introduced instead of an insulin secretion intensifier during intake of food, and where the patient continues receiving the suppressor of glucose production by the liver The group of inventions also relates to improved methods of treating hyperglycemia in patients with the second type of diabetes, who are being treated with the suppressor of glucose production by the liver and the insulin secretion intensifier, with superfast-acting insulin.
EFFECT: application of the obtained group of inventions makes it possible to achieve an improved glycemya control and treatment.
33 cl, 28 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF SUPER-HIGH-SPEED INSULIN | 2014 |
|
RU2688663C2 |
| TREATING DIABETES MELLITUS WITH LONG-ACTING INSULIN FORMULATIONS | 2014 |
|
RU2705797C2 |
| METHOD FOR PREVENTING GLP-1 SIDE EFFECTS | 2008 |
|
RU2474415C2 |
| ACTIVE SUBSTANCE DELIVERY | 2008 |
|
RU2467741C2 |
| LIXISENATIDE AS ADD-ON THERAPY TO BASAL INSULIN IN TYPE 2 DIABETES | 2012 |
|
RU2606154C2 |
| METHODS OF DIACEREIN APPLICATION IN ADDITIONAL TREATMENT OF DIABETES | 2011 |
|
RU2563988C2 |
| PHARMACEUTICAL COMPOSITION | 2013 |
|
RU2670106C2 |
| METHOD OF WEIGHT REDUCTION | 2013 |
|
RU2664442C2 |
| METHOD AND PHARMACEUTICAL COMPOSITIONS FOR TREATING POSTPRANDIAL HYPERGLYCEMIA ACCOMPANYING TYPE II DIABETES MELLITUS BY ADMINISTERING THROUGH ORAL MUCOSA | 2010 |
|
RU2543635C2 |
| LIXISENATIDE AND METFORMIN FOR TYPE 2 DIABETES TREATMENT | 2012 |
|
RU2623023C2 |
